• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    11/12/24 9:50:11 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care
    Get the next $SKIN alert in real time by email
    SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No.7 BEAUTY HEALTH CO/THE CLASS A COMMON STOCK Cusip #88331L108 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #88331L108 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 18,603,037 Item 6: 0 Item 7: 18,603,037 Item 8: 0 Item 9: 18,603,037 Item 11: 14.999% Item 12: HC Cusip #88331L108 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 18,603,037 Item 8: 0 Item 9: 18,603,037 Item 11: 14.999% Item 12: IN Item 1(a). Name of Issuer: BEAUTY HEALTH CO/THE Item 1(b). Address of Issuer's Principal Executive Offices: 2165 SPRING STREET LONG BEACH, CA 90806 USA Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: CLASS A COMMON STOCK Item 2(e). CUSIP Number: 88331L108 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 18,603,037 (b) Percent of Class: 14.999% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 18,603,037 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the CLASS A COMMON STOCK of BEAUTY HEALTH CO/THE. The interest of Fidelity Growth Company Fund, in the CLASS A COMMON STOCK of BEAUTY HEALTH CO/THE, amounted to 6,733,641 shares or 5.429% of the total outstanding CLASS A COMMON STOCK at September 30, 2024. The interest of Fidelity Growth Company Commingled Pool, in the CLASS A COMMON STOCK of BEAUTY HEALTH CO/THE, amounted to 8,312,870 shares or 6.702% of the total outstanding CLASS A COMMON STOCK at September 30, 2024. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. November 8, 2024 Date /s/ Stephanie J. Brown Signature Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification Fidelity Management & Research Company LLC * IA Fidelity Management Trust Company * BK * Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on November 8, 2024, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the CLASS A COMMON STOCK of BEAUTY HEALTH CO/THE at September 30, 2024. FMR LLC By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson** * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
    Get the next $SKIN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SKIN

    DatePrice TargetRatingAnalyst
    11/15/2023$11.00 → $1.50Buy → Hold
    Jefferies
    11/14/2023$10.00 → $2.50Buy → Hold
    Canaccord Genuity
    11/14/2023Neutral → Underweight
    JP Morgan
    11/14/2023$12.00 → $2.00Overweight → Underweight
    Piper Sandler
    11/14/2023$9.00 → $2.50Outperform → Market Perform
    TD Cowen
    11/14/2023Buy → Hold
    The Benchmark Company
    11/14/2023Mkt Perform → Underperform
    Raymond James
    11/14/2023Outperform → Mkt Perform
    William Blair
    More analyst ratings

    $SKIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chairman Saunders Brent L bought $43,686 worth of shares (40,450 units at $1.08), increasing direct ownership by 0.69% to 5,921,769 units (SEC Form 4)

      4 - Beauty Health Co (0001818093) (Issuer)

      8/13/24 5:00:11 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Monahan Michael P. covered exercise/tax liability with 24,290 shares, decreasing direct ownership by 2% to 1,358,662 units (SEC Form 4)

      4 - Beauty Health Co (0001818093) (Issuer)

      6/3/25 4:10:01 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • CSO and COO Lewis Sheri covered exercise/tax liability with 31,296 shares, decreasing direct ownership by 3% to 914,726 units (SEC Form 4)

      4 - Beauty Health Co (0001818093) (Issuer)

      4/11/25 4:46:48 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • President and CEO Beck Marla Malcolm covered exercise/tax liability with 92,981 shares, decreasing direct ownership by 3% to 2,753,401 units (SEC Form 4)

      4 - Beauty Health Co (0001818093) (Issuer)

      4/11/25 4:44:21 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    SEC Filings

    See more
    • The Beauty Health Company filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

      8-K - Beauty Health Co (0001818093) (Filer)

      5/27/25 5:19:53 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • The Beauty Health Company filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Beauty Health Co (0001818093) (Filer)

      5/21/25 4:13:53 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by The Beauty Health Company

      SCHEDULE 13G/A - Beauty Health Co (0001818093) (Subject)

      5/14/25 12:01:27 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • BeautyHealth Surpasses 35,000 Hydrafacial Devices Worldwide Reflecting Growing Consumer Demand for Clinically Proven Skin Health Treatments

      LONG BEACH, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- The BeautyHealth Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, recently achieved a major milestone with 35,000 Hydrafacial devices installed worldwide, reinforcing its market leadership in the hydradermabrasion category it pioneered. This accomplishment highlights the Hydrafacial treatment's continued global demand, fueled by strong brand awareness, and growing consumer preferences for non-invasive, results-driven skin health treatments. "With providers delivering approximately 5 million Hydrafacial treatments last year1, our position as one of the most in-demand professional skin health treatments is clear," said Beaut

      6/4/25 8:00:00 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • The Beauty Health Company Announces Convertible Debt Refinancing

      LONG BEACH, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced that it entered into privately negotiated exchange agreements (the "Exchange Agreements") with certain holders (the "Exchanging Holders") of the Company's outstanding 1.25% convertible senior notes due 2026 (the "Existing Notes"). "Our refinancing marks a critical step in strengthening our financial position and extending a portion of our debt maturity, giving us greater flexibility to invest in long-term, profitable growth," said BeautyHealth Chief Executive Officer Marla Beck. "With a robust pipeline of innovation and bold brand initiatives,

      5/21/25 8:00:00 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • BeautyHealth Reports First Quarter 2025 Financial Results

      LONG BEACH, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2025 ("Q1 2025"). "Our first quarter results reflect strong execution and continued momentum in our transformation strategy," said CEO Marla Beck. "We exceeded both revenue and adjusted EBITDA guidance, driven by gross profit growth and meaningful cost efficiencies. Despite macroeconomic pressures that impacted device sales, consumables revenue remained resilient, reinforcing the strength of our recurring revenue model and sustained consumer dem

      5/8/25 4:05:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • The Beauty Health Company downgraded by Jefferies with a new price target

      Jefferies downgraded The Beauty Health Company from Buy to Hold and set a new price target of $1.50 from $11.00 previously

      11/15/23 7:13:27 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • The Beauty Health Company downgraded by JP Morgan

      JP Morgan downgraded The Beauty Health Company from Neutral to Underweight

      11/14/23 7:45:38 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • The Beauty Health Company downgraded by Canaccord Genuity with a new price target

      Canaccord Genuity downgraded The Beauty Health Company from Buy to Hold and set a new price target of $2.50 from $10.00 previously

      11/14/23 7:45:38 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    Financials

    Live finance-specific insights

    See more
    • BeautyHealth Reports First Quarter 2025 Financial Results

      LONG BEACH, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2025 ("Q1 2025"). "Our first quarter results reflect strong execution and continued momentum in our transformation strategy," said CEO Marla Beck. "We exceeded both revenue and adjusted EBITDA guidance, driven by gross profit growth and meaningful cost efficiencies. Despite macroeconomic pressures that impacted device sales, consumables revenue remained resilient, reinforcing the strength of our recurring revenue model and sustained consumer dem

      5/8/25 4:05:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • BeautyHealth to Report First Quarter 2025 Financial Results on May 8, 2025

      LONG BEACH, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report first quarter 2025 financial results after market close on Thursday, May 8, 2025. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the Company's investor relations website at https://investors.beautyhealth.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure InformationThe Beauty Health Company announces m

      4/29/25 4:00:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • BeautyHealth Reports Full Year and Fourth Quarter 2024 Financial Results

      LONG BEACH, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth"), home to flagship brand Hydrafacial, today announced financial results for the fourth quarter ended December 31, 2024 ("Q4 2024"). "In Q4 2024, we continued to strengthen our financial position, exceeding the high end of our guidance for both net sales and adjusted EBITDA," said CEO Marla Beck. "We increased consumable sales, expanded our gross margins and continued to reduce our operating expenses, delivering $9 million of adjusted EBITDA in the quarter. We now have over 34,000 global delivery systems serving our large provider base." "In 2025, we are focused on deepening

      3/12/25 4:05:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

      SC 13G/A - Beauty Health Co (0001818093) (Subject)

      11/14/24 4:16:27 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

      SC 13G/A - Beauty Health Co (0001818093) (Subject)

      11/14/24 11:27:23 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

      SC 13G/A - Beauty Health Co (0001818093) (Subject)

      11/14/24 11:03:00 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    Leadership Updates

    Live Leadership Updates

    See more
    • The Beauty Health Company Strengthens Commercial Leadership Team with Chief Revenue Officer and Chief Marketing Officer Appointments

      The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of two accomplished industry executives to its commercial leadership team. Ron Menezes will join Beauty Health as Chief Revenue Officer and Carrie Caulkins will join the Company as Chief Marketing Officer, effective October 15, 2024, with both reporting to the Company's Chief Executive Officer, Marla Beck. Mr. Menezes assumes his new role from Dan ("Doc") Watson, who is leaving Beauty Health and will assist with the transition through year-end. Ms. Caulkins fills an open position. Marla Beck commented on the appointments, "We are thrilled to welcome Ron and Carrie to the executive t

      10/15/24 4:10:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • BeautyHealth Names Sheri Lewis as Chief Supply Chain and Operations Officer

      The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced that it has appointed Sheri Lewis as Chief Supply Chain and Operations Officer, effective immediately. Ms. Lewis will report to BeautyHealth's President and Chief Executive Officer, Marla Beck. "Sheri is a talented and deeply experienced executive who brings decades of valuable global operations expertise to BeautyHealth as we chart the future of the Company," said Marla Beck, BeautyHealth President and Chief Executive Officer. "The Board of Directors and I are confident that her deep industry experience across global supply chain and operations will play a critical role in advancing our strategic

      4/9/24 4:10:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • BeautyHealth Announces Appointment Of Marla Beck As Chief Executive Officer

      The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced its Board of Directors has unanimously approved Marla Beck as the Company's permanent President and Chief Executive Officer. Ms. Beck has been Interim CEO since November 20, 2023, in addition to serving on the Company's Board of Directors, which she will continue to do going forward. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240312423257/en/SKIN) (Photo: Business Wire)">Marla Beck, President and Chief Executive Officer, The Beauty Health Company (NASDAQ:SKIN) (Photo: Business Wire) "Over the past few months, the Board has undertaken

      3/12/24 4:05:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care